All In MedTech

Device Trial Radar · NCT07817784

Indonesian Version of Oxford Cognitive Screen-Plus Test in Stroke Patient

Validity and Reliability Test of the Indonesian Version of Oxford Cognitive Screen-Plus in Stroke Patient

Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

75

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Oct 1, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Universitas PadjadjaranAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Oxford
First posted
Sep 14, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The incidence of stroke increases every year throughout the world. Neuropsychological assessment is the best way to identify post-stroke cognitive dysfunction. The importance of cognitive function in the post stroke rehabilitation program process requires a tool that can detect cognitive disorders more specifically and more sensitively. The investigator aim in this study was to develop Indonesian version of the OCS - Plus among stroke patient in Indonesia.

Conditions

  • Post Stroke
  • Cognitive Assessment

Interventions

  • OCS Plus AssessmentDevice

    Subject is going to carry out Indonesian OCS Plus assessment in accordance with the procedure given by the application.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Validity and Reliability of Indonesian OCS PlusTime frame: T0 - Baseline assessment (Day 1) -. Informed consent and Demographic -. MoCA-Ina -. Indonesian OCS-Plus T1 - Retest (48 hours after T0) -.Indonesian OCS-Plus repeated under standardized conditions -.No cognitive rehabilitation intervention between T0-T1

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.